Sterlife Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.43 Cr
- Revenue Growth -18.95%
- Profit Growth -45.35%
- Ebitda -23.45%
- Net Worth 20.35%
- Total Assets -9.64%
About Sterlife Pharma
Sterlife Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 2016 (Eight years and nine months 21 days old ). Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.43 Cr.
Paresh Dobariya, Piyushbhai Pipaliya, and Sandeep Parsana serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24303GJ2016PTC091786
- Company No.
091786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sterlife Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Dobariya  | Director | 02-May-2016 | Current |
| Piyushbhai Pipaliya | Director | 02-May-2016 | Current |
| Sandeep Parsana | Director | 02-May-2016 | Current |
Financial Performance of Sterlife Pharma.
Sterlife Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.95% decrease. The company also saw a substantial fall in profitability, with a 45.35% decrease in profit. The company's net worth Soared by an impressive increase of 20.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sterlife Pharma?
Unlock access to Sterlife Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sterlife Health Care LlpParesh Dobariya, Piyushbhai Pipaliya and 1 more are mutual person
Charges (Loans)
₹14.33 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 1.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2017 | Indian Overseas Bank | ₹1.43 Cr | Open |
How Many Employees Work at Sterlife Pharma?
Sterlife Pharma has a workforce of 20 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sterlife Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterlife Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
